This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) rose 1.64% to $56.48 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.17% to 50,872.11 and the S&amp;P 500 Index falling 0.26% to 7,386.65.
Bristol Myers Squibb Co. closed 10.19% below its 52-week high of $62.89, which the company reached on March 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 2.08% to $237.00, Pfizer Inc. (PFE) rose 0.31% to $25.70, and Abbott Laboratories (ABT) rose 0.83% to $91.25.
Trading volume (11.9 M) eclipsed its 50-day average volume of 10.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-09-26 1637ET

Bristol Myers Squibb (BMY) shares rose 1.64% to $56.48 on Tuesday, outperforming the S&P 500 but underperforming key competitors like Johnson & Johnson and Pfizer. Trading volume exceeded its 50-day average. The stock remains 10.19% below its 52-week high of $62.89 reached in March.

MarketWatch Automated

Bristol Myers Squibb

Dow Jones Industrial Average

S&P 500

Johnson & Johnson

Pfizer

Abbott Laboratories

Factset Research

Bristol-Myers Squibb Company

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains